Clinical Features, Outcomes, and Therapeutics of Pregnancy-Related Aortic Dissection

Sponsor
Nanjing Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT05501145
Collaborator
Beijing Anzhen Hospital (Other), Shanghai Zhongshan Hospital (Other), Guangdong Province Hospital (Other)
75
4
6.9
18.8
2.7

Study Details

Study Description

Brief Summary

Aortic dissection in pregnancy represents a lethal risk to both the mother and fetus, it has yet to yield the optimal therapeutic strategy. The aim of this study was to characterize the clinical features and outcomes in women with pregnancy-related acute aortic dissection, and to suggest therapeutic guidelines.

Condition or Disease Intervention/Treatment Phase
  • Procedure: cesarean section and aortic repair

Study Design

Study Type:
Observational
Actual Enrollment :
75 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Clinical Features, Outcomes, and Therapeutics of Ppregnancy-related Aortic Dissection
Actual Study Start Date :
Jan 1, 2022
Actual Primary Completion Date :
Jul 31, 2022
Actual Study Completion Date :
Jul 31, 2022

Outcome Measures

Primary Outcome Measures

  1. 30-day mortality [30 days after surgery]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women who presented with aortic dissection during pregnancy or post partum ≤12 weeks.
Exclusion Criteria:
  • Loss of surgical information.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beijing Anzhen Hospital Beijing China 10029
2 Department of Obstetrics and Gynecology, Guangdong Provincial People's Hospital Guangzhou China
3 Department of Cardiac Surgery, Affiliated Hospital of Qingdao University Qingdao China
4 Department of Obstetrics and Gynecology, Zhongshan Hospital Shanghai China

Sponsors and Collaborators

  • Nanjing Medical University
  • Beijing Anzhen Hospital
  • Shanghai Zhongshan Hospital
  • Guangdong Province Hospital

Investigators

  • Study Chair: Hong-jia Zhang, MD, Beijing Anzhen Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hong Liu, Principal Investigator of Cardiovascular Surgery, Nanjing Medical University
ClinicalTrials.gov Identifier:
NCT05501145
Other Study ID Numbers:
  • 5A Plan VII
First Posted:
Aug 15, 2022
Last Update Posted:
Aug 15, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 15, 2022